SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-022252
Filing Date
2017-11-07
Accepted
2017-11-07 16:16:51
Documents
83
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctmx-10q_20170930.htm 10-Q 1842053
2 EX-4.4 ctmx-ex44_91.htm EX-4.4 158898
3 EX-10.1 ctmx-ex101_92.htm EX-10.1 676450
4 EX-31.1 ctmx-ex311_8.htm EX-31.1 19579
5 EX-31.2 ctmx-ex312_10.htm EX-31.2 19590
6 EX-32.1 ctmx-ex321_11.htm EX-32.1 10162
7 EX-32.2 ctmx-ex322_9.htm EX-32.2 10527
8 GRAPHIC g20171107185720520568.jpg GRAPHIC 4507
9 GRAPHIC g20171107185720522569.jpg GRAPHIC 3378
  Complete submission text file 0001564590-17-022252.txt   8010186

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT ctmx-20170930.xml EX-101.INS 1502262
11 XBRL TAXONOMY EXTENSION SCHEMA ctmx-20170930.xsd EX-101.SCH 65308
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ctmx-20170930_cal.xml EX-101.CAL 44641
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctmx-20170930_def.xml EX-101.DEF 207374
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctmx-20170930_lab.xml EX-101.LAB 418231
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctmx-20170930_pre.xml EX-101.PRE 363268
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37587 | Film No.: 171183573
SIC: 2834 Pharmaceutical Preparations